14-3-3 proteins are intracellular dimeric phosphoserine/threonine-binding molecules that participate in signal transduction and checkpoint control pathways. 14-3-3 proteins are required for normal eye development, brain function, and terminal patterning in Drosophila melanogaster, but the role of 14-3-3 proteins in vertebrate development is undefined. In this work an unphosphorylated peptide inhibitor of 14-3-3, R18, was used to determine the role of 14-3-3 proteins in Xenopus embryonic development. Biochemical analysis demonstrated that R18 was specific and efficient at attenuating global 14-3-3 activities in Xenopus embryos. Microinjection experiments showed a requirement for 14-3-3 function in mesodermal specification. Inhibition of 14-3-3 resulted in embryos with axial patterning defects and reduced expression of mesodermal marker genes. These phenotypic defects were caused by impaired fibroblast growth factor signaling in R18-injected embryos. These results establish the importance of 14-3-3 proteins in vertebrate embryonic development. q
Introduction
Vertebrate embryonic development is dependent on inductive interactions that lead to the formation of different cell types. Secreted factors such as growth factors and cytokines appear to play a key role in regulating these events. In particular, the TGF-b, FGF, Wnt, Notch, and hedgehog family of growth/differentiation factors are thought to regulate important inductive interactions. These secreted factors bind to cell surface receptors in responding cells, resulting in the activation of intracellular signaling cascades that culminate in altered gene expression.
14-3-3 proteins are acidic, intracellular, dimeric proteins that participate in several signal transduction cascades (Fu et al., 2000) . 14-3-3 proteins have the ability to bind avidly to several phosphoserine and phosphothreonine motifs, including the canonical RSXpSXP motif (where X is any amino acid and pS is phosphoserine) (Muslin et al., 1996; Yaffe et al., 1997) . Although 14-3-3 proteins are abundant, their expression is regulated, and 14-3-3 gene induction occurs in response to mitogen stimulation and to environmental stimuli (Hermeking et al., 1997; Angelastro et al., 2000) . 14-3-3 binding to partner proteins can affect the enzymatic activity, subcellular localization, and/or stability of its partners (Muslin and Xing, 2000) . In some cases, the spatial proximity of 14-3-3 binding motifs to other important information-containing domains determines the effect of 14-3-3 binding. For example, 14-3-3 binding to the cell cycle protein phosphatase cdc25c effects it's subcellular localization by obscuring a nearby nuclear localization signal (Dallal et al., 1999; Kumagai and Dunphy, 1999) .
14-3-3 proteins bind to the mitogen-activated protein kinase kinase kinases (MAPKKKs) Raf-1, B-Raf, Ask1, and MEKK1 (Fantl et al., 1994; Freed et al., 1994; Fu et al., 1994; Irie et al., 1994; Papin et al., 1996; Zhang et al., 1999) . In the case of Raf-1, 14-3-3 binds to at least two, and perhaps three, different sites on both the amino and carboxyportions of the protein. 14-3-3 binding to serine-621 at the carboxy-terminus of Raf-1 may be essential for Raf-1 activity, while 14-3-3 binding to serine-259 inhibits Raf-1 activity Roy et al., 1998; Thorson et al., 1998) . In one model, 14-3-3 plays a critical role in the regulation of Raf-1 activity (Thorson et al., 1998) . First, 14-3-3 maintains Raf-1 in an inactive conformation and also localizes Raf-1 to the cytoplasmic compartment in the absence of ras activity. Second, 14-3-3 binding is required for ras-GTP to bind to Raf-1 and to relocalize Raf-1 to the plasma membrane. Ras-GTP likely displaces 14-3-3 from serine-259 of Raf-1 (Rommel et al., 1996) , while 14-3-3 binding to serine-621 of Raf-1 may or may not be maintained (Roy et al., 1998; Thorson et al., 1998) . Third, binding to serine-621 of ras-GTP-activated Raf-1 is required for enzymatic activity and also possibly to recruit substrate proteins (Muslin et al., 1996; Thorson et al., 1998; MacNicol et al., 2000) . In this stepwise fashion, 14-3-3 is hypothesized to be a positive regulator of the ras-Raf-MEK-ERK MAPK cascade.
To complement the biochemical data supporting a positive role of 14-3-3 in Raf-1 activation, a variety of data from genetic study supports the notion that 14-3-3 proteins play an important role in ras-mediated ERK MAPK activation. In budding yeast, the 14-3-3 homologues bmh1 and bmh2 are essential components of the pseudohyphal ras-ERK MAPK cascade (Roberts et al., 1997) . In this pathway, bmh1 and bmh2 bind to the protein kinase ste20p, a homologue of mammalian PAKs. In Drosophila, both D14-3-3 1 and z are shown to play positive role in the Ras/Raf/MAPK cascade that mediates Raf-dependent photoreceptor development (Kockel et al., 1997; Chang and Rubin, 1997) .
Genetic epistasis experiments in Drosophila demonstrated that 14-3-3 acts between Ras and MEK. It was also determined in Drosophila that 14-3-3 proteins are required for normal brain function and terminal patterning Davis, 1996, 1998; Li et al., 1997) .
Little is known about the role of 14-3-3 family members in vertebrate development. Two Xenopus 14-3-3 isoforms, x14-3-3z and x14-3-31 have been identified (Kousteni et al., 1997; Kumagai et al., 1998) . The spatial expression pattern of x14-3-3z at the tadpole stage was examined by whole mount in situ hybridization and the strongest expression was observed in brain, optic vesicles, branchial arches, spinal cord and notochord (Kousteni et al., 1997) . The biological importance of 14-3-3 proteins in vertebrate embryonic development is unexplored, in large part, because of the multiplicity of 14-3-3 isoforms expressed in most vertebrate tissues. Indeed, there are at least seven different 14-3-3 isoforms, encoded by separate genes, in mammals. Disruption of the 14-3-3 sigma gene has been performed in embryonic mammalian stem cells by one group, but disruption of this gene in an intact animal has not been described (Chan et al., 1999) . Targeted deletion of other 14-3-3 genes in murine model systems has not been reported at this time.
In this work, we utilized a different approach to inhibit 14-3-3 function in embryonic development. We used a nonphosphorylated peptide inhibitor of 14-3-3 action that was identified in a peptide library screen (Wang et al., 1999) . This peptide, called R18, efficiently and specifically binds to the phosphoserine-binding pocket of all tested 14-3-3 isoforms (b, z, t) and blocks the ability of 14-3-3s to bind to target proteins, such as Raf-1, B-Raf, and Ask1 (Wang et al., 1999) . By use of the R18 peptide, we determined that 14-3-3 activity is required for Xenopus mesodermal patterning in early embryonic development.
Results

Construction and expression of a GST-R18 fusion protein
The non-phosphorylated R18 peptide was previously determined by phage display screening to bind to 14-3-3 isoforms with high affinity (Wang et al., 1999) . The consensus sequence WLDL in R18 was determined to be critical for 14-3-3 binding. A cDNA was constructed that encoded a fusion protein that included full-length glutathione S-transferase (GST) followed in-frame by the R18 peptide (GST-R18), or by a mutant form of the peptide in which the WLDL tetrapeptide is mutated to ALAL (GST-R18M). Xenopus embryos were microinjected with RNA encoding GST, GST-R18, or GST-R18M. The injected whole cell cytosolic lysates showed prolonged production of a fusion protein that was easily detectable by anti-GST immunoblotting. The GST-R18 and GST-R18M fusion proteins exhibited slower mobility in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) when compared to GST protein (Fig. 1A) . Injection of both cells of two-cell embryos at the vegetal pole with 20 ng RNA encoding GST-R18 resulted in detectable protein levels from stage 6 through stage 40, a period of at least 72 h (Fig. 1B) . GST-R18 protein levels peaked at stage 14, but remained consistently high at least until stage 40.
GST-R18 binds to 14-3-3 proteins in Xenopus embryos
To determine whether the GST-R18 fusion protein can bind to and inactivate native 14-3-3 proteins, a series of affinity chromatography experiments was performed. Xenopus embryos were injected with RNA encoding GST, GST-R18M or GST-R18. After 24 h, protein lysates were obtained. GST, GST-R18M and GST-R18 fusion proteins from cell lysates were immobilized on glutathione-sepharose 4B beads, washed vigorously, and then adherent proteins were separated by SDS-PAGE and analyzed by anti-pan-14-3-3 immunoblotting. GST-R18 protein, but not GST, nor the mutant GST-R18, GST-R18M, bound to native 14-3-3 proteins in injected embryos (Fig. 1A) . To estimate the stability of the GST-R18-14-3-3 association during early development, lysates of GST-R18 injected embryos at different stages were collected for GST pulldown assays. GST-R18 protein was initially detected at the 32-cell stage and persisted until at least stage 40 (Nieuwkoop and Faber, 1967) . In addition, the amount of bound 14-3-3 protein correlated to the GST-R18 expression level (Fig.  1B) . These results indicate that GST-R18 protein is stable and functional during Xenopus early embryogenesis.
We next examined the efficiency of GST-R18 binding to 14-3-3 proteins, to determine the percentage of endogenous 14-3-3 protein in embryonic lysates that are associated with, and inhibited by, the R18 peptide. Xenopus embryos were injected with RNA encoding GST or GST-R18, and lysates were obtained. Each lysate was divided into two, and half of the lysate was incubated with glutathione-sepharose beads for 4 h, separated by centrifugation, and the supernatant was collected. The other half of the lysate and lysate that had been pre-cleared by the glutathione-sepharose beads were analyzed by anti-14-3-3 beta (pan-14-3-3) or anti-GST immunoblotting ( Fig. 2A) . Glutathione-sepharose pre-clearance depleted about 70-80% of endogenous 14-3-3 proteins Fig. 2 . The GST-R18 fusion protein efficiently inhibits 14-3-3 activity in Xenopus embryos. (A) Depletion of 14-3-3 protein by GST-R18 in vivo. Xenopus two-cell embryos were injected with RNA encoding GST or GST-R18 and protein lysates were obtained from stage 14 embryos. Each lysate was divided into two and half the lysate was incubated with glutathionesepharose 4B beads for 4 h, separated by centrifugation, and the supernatant was collected. The control half of the lysate (Lys) and the supernatant precleared by glutathione-sepharose beads (GST-PD) were separated by SDS-PAGE and analyzed by anti-pan-14-3-3 (upper panel) or anti-GST immunoblotting (lower panel). Note the reduction of 14-3-3 protein in GST-R18-injected embryonic lysates after glutathione-sepharose chromatography. (B) The GST-R18 fusion protein inhibits the association of 14-3-3 with Raf-1 in Xenopus oocytes. Oocytes were injected with 40 ng of RNA encoding GST or GST-R18. Oocyte protein lysates were obtained 24 h after control or RNA injection and lysates were analyzed by anti-Raf-1, anti-pan-14-3-3, or anti-GST immunoblotting (upper 3 panels). Anti-Raf-1 (C-12, Santa Cruz Biotech) immunoprecipitates obtained from whole cell lysates were immunoblotted with anti-Raf-1 or anti-pan-14-3-3 antibodies (lower 2 panels). GST-R18 fusion protein binds to 14-3-3 in embryos. Xenopus two-cell embryos were injected with 20 ng RNA encoding GST, GST-R18, or the mutant fusion protein GST-R18M. Protein lysates were generated at embryonic stage 14 (Nieuwkoop and Faber, 1967) . In the upper panel, protein lysates were separated by SDS-PAGE, transferred to nitrocellulose membranes, and probed with an anti-GST antibody or with an anti-pan-14-3-3 antibody (anti-14-3-3b). In the lower panel, protein lysates were added to glutathione-sepharose 4B beads to immobilize GST-containing proteins and washed four times. Bound proteins were separated by SDS-PAGE, transferred to nitrocellulose membranes, and immunoblotted with an anti-GST antibody (upper panel) or with an anti-pan-14-3-3 antibody (anti-14-3-3b) . Note the slightly slower mobility of the GST-R18 and GST-R18M fusion proteins compared to GST alone in the immunoblot. (B) Injection of RNA encoding GST-R18 results in prolonged expression of GST-R18 protein that binds to 14-3-3 in vivo. Twenty nanograms of GST-R18 RNA was injected into two-cell stage embryos. Whole embryo lysates at the indicated embryonic stages were generated and analyzed by anti-GST immunoblotting to determine GST-R18 protein levels after RNA injection (upper panel). Parallel lysates were utilized in GST pull-down assays as described earlier in (A).
from GST-R18 injected embryo lysates ( Fig. 2A) . Glutathione-sepharose pre-clearance did not deplete endogenous 14-3-3 proteins from uninjected or GST injected lysates. These results show that GST-R18 protein avidly binds to 14-3-3. To show that GST-R18 inhibits 14-3-3 activity, co-immunoprecipitation experiments were performed that demonstrated that Raf-1 binding to 14-3-3 was blocked in GST-R18-injected embryos (Fig. 2B) .
Proteins that interacted with GST, GST-R18M, or GST-R18 were also analyzed by silver staining, which revealed that GST-18 specifically interacted with proteins of 29-31 kDa, the apparent molecular weight of 14-3-3 proteins (Fig. 3) . Proteins of molecular weight more or less than 29-31 kDa did not bind to the GST-R18.
GST-R18 protein blocks axial patterning
Since the GST-R18 fusion protein is a robust and stable inhibitor of 14-3-3 activity in Xenopus embryos, we used this reagent to determine the biological function of 14-3-3 proteins in embryonic development. Previous studies showed that endogenous x14-3-31 and x14-3-3z are each present at a concentration of about 40 mg/ml in Xenopus egg extracts (Kumagai et al., 1998) . Therefore, 14-3-3 proteins are very abundant in Xenopus embryos, especially given that other 14-3-3 isoforms may also be present. We found that injection of a large amount of GST-R18 RNA was required to block 14-3-3 activity in the embryos. When both cells of two-cell embryos were microinjected at the marginal zone with 20 ng of GST-R18 RNA, a stereotypical set of phenotypic abnormalities resulted. The GST-R18 injected embryos formed a blastopore lip normally, but a large number of them (72%) failed to complete gastrulation (Table 1) . At the mid-to-late gastrula stage, the closure of the lateral and ventral regions of the blastopore was suspended, and to some extent, underwent evagination instead of invagination, resulting in an open blastopore in later neurula stages (Fig. 4B, arrow head) . When 20 ng of RNA encoding GST alone was injected, only 14% of embryos showed similar defects in gastrulation (Table 1) . Fig. 3 . The GST-R18 fusion protein binds specifically to 14-3-3 proteins. Embryos were injected with 20 ng of RNA encoding GST, GST-R18M, or GST-R18 at the two-cell stage. Protein lysates of control or RNA injected embryos were obtained from stage 14 embryos. Protein lysates were added to glutathione-sepharose beads, washed, and adherent proteins were separated by SDS-PAGE and visualized by silver staining. The bracket indicates the specific proteins bound to the R18 moiety of the GST-R18 fusion protein, running at the apparent molecular weight of ,29 kDa. Reduced and disorganized skeletal muscle development in stage 40 GST-R18 injected embryos. Two-cell embryos were injected in both blastomeres with RNA encoding GST-R18M (E) or GST-R18 (F). Each blastomere was injected with 20 ng of RNA. Embryos were fixed, embedded in paraffin, sectioned and probed with muscle-specific antibody 12/101 (Kintner and Brockes, 1984) . Skeletal muscle was visualized with a red substrate (indicated by arrows). (G,H) Bent anteroposterior axis in stage 40 embryos injected unilaterally with GST-R18. Two-cell embryos were injected in one blastomere with 20 ng RNA encoding GST-R18M (G) or GST-R18 (H).
The GST-R18M injected embryos formed a closed blastopore (Fig. 4A) . When GST-R18 embryos were allowed to develop to the tadpole stage, they displayed posterior axial defects similar to those observed in embryos overexpressing dominant negative FGF receptor (Amaya et al., 1991) , dominant negative H-ras (Whitman and Melton, 1992) or dominant negative Raf-1 (MacNicol et al., 1993) . Despite comparatively normal development of anterior structures, including the eyes and cement gland, trunk structures were severely diminished in GST-R18 embryos (Fig. 4D) . Immunocytochemical analysis of GST-R18 embryos with the muscle-specific 12/101 antibody (Kintner and Brockes, 1984) showed decreased and disorganized skeletal muscle (Fig. 4F) . Control embryos injected with GST-R18M RNA developed normal posterior structures, including well-organized somites (Fig. 4C, E) . When 20 ng of GST-R18 RNA was injected into the marginal zone of only one blastomere of two-cell stage embryos at the marginal zone, 20 out of the 47 embryos completed gastrulation normally. However, when unilaterally injected GST-R18 embryos that had gastrulated normally were evaluated at the tadpole stage, 17 out of the 20 of them were severely bent (Fig. 4H) , indicating a defect in axial structure formation. When the same amount of RNA encoding GST-R18M was microinjected into one blastomere of two-cell stage embryos, 15 out of the 16 injected embryos gastrulated normally, and 13 of the 15 appeared completely normal when evaluated at the tadpole stage (Fig. 4G) .
To examine whether the phenotypic abnormalities observed were due to a defect of mesoderm formation, a series of microinjection experiments were performed, and marker genes expression was analyzed by whole mount in situ hybridization. First, marginal zone 14-3-3 activity was inhibited by injecting 10 ng RNA of GST-R18, or GST-R18M equatorially into each of the four blastomeres of four-cell stage embryos. Whole mount in situ hybridization of stage 10.25 embryos showed that the expression of Xbra, a well-described early genetic marker of general mesoderm in Xenopus embryos , was blocked in GST-R18 injected embryos (9/10), compared to GST-R18M injected embryos (Fig. 5A, B) . Second, 14-3-3 activity was inhibited in a more localized fashion by injecting the RNA into one blastomere of two-cell embryos, or two alternative blastomeres of four-cell embryos at the marginal zone. Embryos were fixed at the early gastrula stage to examine 
of GST-R18 injected embryos (D). (E,F)
Four-cell embryos were injected equatorially into two blastomeres with 10 ng of RNA per blastomere. Note the reduced Xbra expression in two of the four quadrants (indicated by arrows) in the GST-R18 injected embryos (F). (G,H) GST-R18 inhibits XmyoD expression. Two-cell embryos were injected equatorially in one blastomere with 20 ng of RNA per blastomere. Note the reduced XmyoD expression on the injected side (indicated by arrow) of the GST-R18 injected embryo (H). (I,J) GST-R18 inhibits Xwnt8 expression. Two-cell embryos were injected equatorially in one blastomere with 20 ng of RNA per blastomere. Note the reduced Xwnt8 expression on the injected side (indicated by arrow) of the GST-R18 injected embryo (J). (K,L) GST-R18 does not inhibit goosecoid expression. Four-cell embryos were injected equatorially in two blastomeres with 10 ng of RNA per blastomere. (M,N) GST-R18 does not inhibit chordin expression. Four-cell embryos were injected equatorially in two blastomeres with 10 ng of RNA per blastomere. the expression of Xbra, and the ventral lateral mesoderm markers, XmyoD (Hopwood et al., 1989) and Xwnt8 (Smith and Harland, 1991) . Microinjection of RNA encoding GST-R18 in the marginal zone resulted in a complete block of Xbra expression in the injected side (23/25 embryos) (Fig.  5D) , while 26/30 GST-R18M injected embryos displayed normal Xbra expression (Fig. 5C ). When embryos were injected alternatively into two blastomeres at the four-cell stage embryos with GST-R18 RNA, Xbra expression was blocked only in the injected quadrants (Fig. 5E, F) . Similarly, when GST-R18 was injected into one-half of the embryo, expression of XmyoD and Xwnt8 was inhibited in the injected half (Fig. 5G-J) . These data show that general and lateral-ventral mesoderm markers are down-regulated in gastrula stage embryos injected with GST-R18 RNA.
To test whether the impaired axial patterning defects in GST-R18 injected embryos was due to failure of organizer formation, we analyzed the expression of organizer maker genes. Cleaving embryos were injected in two adjacent sites flanking the cleavage furrows at the four-cell stage with RNA encoding GST-R18 or GST-R18M to ensure localized expression in the organizer (Cho et al., 1991) . As shown in Fig. 5K -N, the expression of goosecoid (Cho et al., 1991) and chordin (Sasai et al., 1994) , markers of the dorsal lip of the blastopore, were not affected by expression of GST-R18. Together, these observations suggest that inhibition of 14-3-3 activity in the marginal zone blocks mesoderm formation.
GST-R18 protein blocks FGF-mediated mesoderm induction in animal caps
Previous work demonstrated that FGF-dependent signaling is required for mesodermal induction, maintenance, and patterning. In particular, FGF is thought to act as a competence factor that permits ectodermal cells to respond to an inductive signal that is presumably a TGF-b family member such as Xnr1, Xnr2, Xnr4, or derriere (Jones et al., 1995; Lustig et al., 1996; Joseph and Melton, 1997; Kofron et al., 1999; Sun et al., 1999; Takahashi et al., 2000) . In addition, FGF signaling is required as a maintenance factor so that induced cells remain in the mesodermal program (Kroll and Amaya, 1996) . Although FGF may not directly induce mesoderm in intact embryos, FGF-mediated mesoderm induction occurs in explanted animal cap ectoderm. To evaluate whether the apparent axial patterning defects observed in GST-R18 embryos were secondary to reduced FGFmediated signal transduction, and not to disruption of another signaling cascade, such as the Wnt pathway, we performed a series of animal cap experiments. Four-cell stage embryos were injected into the animal pole of each blastomere with RNA. Animal caps were isolated from stage 9 embryos and incubated with bFGF (50 ng/ml). To detect expression of Xbra, animal caps were incubated with bFGF or control buffer for 3 h. Total RNA was purified from animal caps and reverse transcriptase polymerase chain reaction (RT-PCR) experiments were performed by use of Xbra specific primers to detect the Xbra expression level. FGF-induced Xbra expression was observed in GSTinjected animal caps, but Xbra expression was blocked by GST-R18 (Fig. 6 ). To determine whether the effect of GST-R18 was specific to the inhibition of 14-3-3 activity, coinjection experiments were performed with RNA encoding wild type 14-3-3z. Inhibition of Xbra expression in GST-R18-injected animal caps was rescued by co-injection with RNA encoding wild type 14-3-3z (Fig. 6) . Xbra expression was not detected in animal caps injected with only 14-3-3z without FGF stimulation (data not shown).
Although co-injection experiments demonstrated that the effect of GST-R18 on FGF-mediated mesoderm induction was specific to 14-3-3, they did not establish which signaling pathway was affected. To prove that GST-R18 acted by interfering with the ras-ERK MAPK pathway, a second set of rescue experiments was performed with a constitutively active form of MEK (CA-MEK). CA-MEK consists of an amino-terminal deletion and two serine-to-glutamic acid mutations (S218, 222E) (Huang and Erikson, 1994; Alessandrini et al., 1996) . Previous work demonstrated that Raf-1, MEK and MAPK activities rapidly decline following fertilization in Xenopus embryos and remain undetectable until the mid-blastula stage (stage 8) (MacNicol et al., 1995) . Inappropriate reactivation of MAPK activity during early blastula stages results in metaphase cell cycle arrest (MacNicol et al., 1995) . To avoid this experimental problem, a DNA expression system was used in which the CA-MEK cDNA was subcloned downstream of the Xenopus borealis cytoskeletal actin (CSKA) promoter (Harland Fig. 6 . 14-3-3 activity is required for FGF-induced mesoderm induction in Xenopus animal caps. Forty nanograms of RNA encoding GST, GST-R18, or X14-3-3z was injected in the animal pole of all cells of four-cell embryos. Animal caps were dissected from stage 9 embryos and incubated in the presence or absence of bFGF (50 ng/ml) for 3 h. Total RNA was purified from animal caps and used in RT-PCR experiments with established primers. EF-1a expression was analyzed as a control. RNA purified from whole embryos at stage 14 was used as a positive control. Note that GST-R18, but not GST, blocked FGF-induced Xbra gene expression in animal caps. Injection of RNA encoding x14-3-3 z rescued the inhibition of Xbra expression in GST-R18 injected animal caps. and Misher, 1988) . When plasmid DNA is injected into the animal pole of four-cell embryos, the cDNA is not transcribed and translated until the mid-blastula transition at stage 8. Animal caps from embryos injected with GST-R18 or GST-R18 RNA, or CSKA-CA-MEK DNA were dissected from stage 9 embryos, and incubated in the presence or absence of bFGF (50 ng/ml) for 8 h. Mesoderm induction in response to FGF stimulation was scored by elongation and by the expression of Xbra in the animal caps that was determined by whole mount in situ hybridization. GST-R18 blocked FGF-mediated mesoderm induction as measured by animal cap elongation (from 94 to 10%) and Xbra expression (from 89 to 16%) ( Table 2 ). Co-injection of GST-R18 with CSKA-CA-MEK DNA rescued FGFmediated mesoderm induction (Table 2) . Mesoderm induction did not occur in CSKA-CA-MEK DNA injected animal caps that were not treated with FGF. These data show that a low dose of CA-MEK, which by itself is insufficient to induce mesoderm, is able to rescue the blockade of FGFmediated mesoderm induction by GST-R18.
Discussion
In this work, we extend previous observations about intracellular signaling proteins and their function in Xenopus mesodermal patterning. Previous work examined the importance of the FGF receptor (Amaya et al., 1991) , the linker proteins Nck and Grb2 (Gupta and Mayer, 1998) , the protein tyrosine phosphatase SHP-2 (O'Reilly and Neel, 1998), the src-like kinase Laloo (Weinstein et al., 1998) , the small GTPase H-ras (Whitman and Melton, 1992) , Raf-1 (MacNicol et al., 1993) , MEK and ERK MAPK (Hartley et al., 1994; Gotoh et al., 1995; Labonne et al., 1995; Umbhauer et al., 1995; Curran and Grainger, 2000) in mesoderm induction and axial patterning. Taken together, these results demonstrate that FGF-mediated effects on mesoderm induction, maintenance, and patterning are dependent on the proper functioning of the ras-MAPK signal transduction cascade. Our findings demonstrate that 14-3-3 proteins play a positive role based on the observation that reduction of the overall 14-3-3 protein level by a peptide inhibitor impairs the ras-MAPK signaling pathway.
For many years, it was known that the in vitro addition of bFGF, eFGF, or other FGFs to Xenopus animal cap ectoderm results in mesoderm induction (reviewed by Slack, 1994) . Inhibition of FGF signaling by microinjection of RNA encoding a dominant negative form of the FGF receptor (XFD) blocks mesoderm induction in intact embryos (Amaya et al., 1991) . Despite these findings, FGF protein is not found in the presumed correct location (vegetal cells) to induce mesoderm in vivo, but is localized in animal and marginal zones of blastula-stage embryos. Therefore, the precise role of FGF in mesoderm induction remains uncertain. One current model is that FGF-mediated signaling is required for marginal zone ectoderm to be competent to respond to a mesoderm-inducing TGF-b-like factor that is secreted by vegetal cells, such as Xnr1, Xnr2, Xnr4 or derriere. In addition, FGF signaling is thought to be required for mesodermal maintenance after the initial inductive signal is received (Kroll and Amaya, 1996) . FGFmediated signaling is also important for the process of gastrulation.
Biochemical and genetic evidence support the notion that 14-3-3 proteins are positive regulators of the ras-MAPK signaling pathway. This evidence is particularly strong in Drosophila melanogaster, where 14-3-3 acts between ras and MEK by genetic epistasis analysis (Chang and Rubin, 1997) . These results led us to hypothesize that a reduction in 14-3-3 activity in early Xenopus embryos might block FGFmediated mesodermal patterning. In order to reduce 14-3-3 activity, we used the non-phosphorylated peptide inhibitor R18 in the form of a GST fusion protein (GST-R18). Microinjection of GST-R18 RNA resulted in the robust and prolonged expression of GST-R18 protein. GST-R18 efficiently bound to native 14-3-3 protein and reduced the amount of 14-3-3 bound to its native targets.
GST-R18 injection into both cells of two-cell embryos resulted in a markedly increased rate of exogastrulation (72%) when compared to injection of GST alone (14%), ¼ 25) and this resulted in an open blastopore phenotype at the neurula stage. Tadpole embryos injected with GST-R18 displayed severe defects in axial patterning, characterized by shortened trunk and reduced and disorganized muscle formation. To examine if the observed phenotype was due to altered mesoderm induction, we analyzed marker gene expression in GST-R18 injected embryos. The organizer markers, goosecoid and chordin, were not affected, while the general mesoderm marker, Xbra, and ventral lateral mesoderm makers, XmyoD and Xwnt8, were inhibited by GST-R18, demonstrating that 14-3-3 activity is required for normal mesoderm induction, rather than the formation of the Spemann organizer. To determine which growth factor-mediated signaling pathway was affected by GST-R18, animal cap assays were performed. These assays demonstrated that FGF-induced mesoderm induction and gene expression was blocked in GST-R18-injected animal caps.
In conclusion, our results demonstrate a clear requirement for 14-3-3 activity in embryonic patterning. In particular, 14-3-3 activity is required for FGF-mediated mesoderm induction. The role of 14-3-3 proteins in development may not be restricted to mesoderm induction, since only 70-80% of total 14-3-3 protein was blocked by GST-R18. Further experiments are required to determine the precise functions of individual 14-3-3 isoforms in early Xenopus embryonic development.
Experimental procedures
Constructs
Two complementary oligonucleotides (forward, 5 0 -GGT-ACCCCACTGTGTCCCCCGAGATCTTTCGTGGTTAG-ATTTAGAAGCAAATATGTGTTTACCCTAGTCTAG-A-3 0 ; and reverse, 5 0 -TCTAGACTAGGGTAAACACATA-TTTGCTTCTAAATCTAACCACGAAAGATCTCGGG-GGACACAGTGGGGTACC-3 0 ) were synthesized and annealed to form the DNA fragment that will encode the 20 amino acid R18 peptide (PHCVPRDLSWLDLEAN-MCLP). This DNA fragment was then digested by BamH1 and Xba I and cloned into a frog expression vector pXen1, downstream and in-frame with the GST portion, to encode the GST-R18 fusion protein. A control fusion protein named GST-R18M was generated by mutating the consensus sequence WLDL to ALAL. CSKA-CA-MEK plasmid DNA was constructed by inserting the HindIIIBamHI fragment containing the encoding sequence of CA-MEK downstream of the CSKA promoter region in the CSKA vector (Harland and Misher, 1988) .
Xenopus embryo injections and animal cap assays
Purified plasmid DNA (pXen1) encoding GST alone, GST-R18, and GST-R18M was linearized and used for in vitro transcription. In vitro fertilization of Xenopus laevis eggs was performed as described previously (MacNicol et al., 1993) . Embryos were staged as described by Nieuwkoop and Faber (1967) . RNA was injected into the vegetal pole of both blastomeres of a two-cell embryo for global expression experiments, or was injected into the marginal zone of twocell or four-cell stage embryos for specific expression in the marginal zone area. RNA (10-20 nl) at a concentration of 1 mg/ml, or approximately 100 pg of supercoiled DNA was injected per blastomere. Embryos were maintained at 198C.
For animal cap assays, RNA or DNA was injected into the animal pole of all the blastomeres in a four-cell embryo. Animal caps were isolated manually from stage 9 embryos and were stimulated with recombinant bFGF for 3 or 8 h as previously described (MacNicol et al., 1993) .
Immunocytochemical analysis of embryos
Embryos were fixed in 10% neutral buffered formalin solution. Dehydrated embryos were embedded in paraplast, sectioned at 7 mm by use of a rotary microtome. The sections were deparaffined and incubated with the muscle specific antibody 12/101 (Kintner and Brockes, 1984) (Developmental Studies Hybridoma Bank). Bound antibody was visualized by alkaline phosphatase-conjugated secondary antibody and Vector red color substrate (Vector Laboratories). Sections were counterstained with hematoxylin.
Protein analysis
Xenopus oocytes and embryos were lysed using NP40 lysis buffer (0.5% NP-40, 137 mM NaCl, 50 mM NaF, 5 mM EDTA, 10 mM Tris [pH 7.5], 1 mM NaVO 3 , 2 mM phenylmethylsulfonyl fluoride, 25 mM leupeptin, 0.2 U/ml aprotinin). After centrifugation, the aqueous layer was transferred to a clean microfuge tube for further use.
For Western blot experiments, proteins were separated by SDS-PAGE and electrophoretically transferred to nitrocellulose filters. Filters were blocked with 5% non-fat dried milk in TBS/T (10 mM Tris [pH 7.5], 150 mM NaCl, 0.1% Tween 20). After incubation in primary antibody, bound antibody was visualized with alkaline phosphatase or horseradish peroxidase-coupled secondary antibody and color-developing agents (Sigma) or chemiluminescencedeveloping agents (ECL, Amersham).
For GST pull down assays, the upper aqueous phases were added to glutathione-sepharose 4B beads to immobilize GST-containing proteins. After mixing with the protein lysates for 1 h at 48C, the beads were washed four times with NP40 buffer. The bound proteins were then subjected to SDS-PAGE and immunoblotting.
For co-immunoprecipitation assays, anti Raf-1 antibody (C-12, Santa Cruz Biotech) was added to the upper aqueous phases. The cell lysates were incubated at 48C for 1 h with mixing. To immobilize antibody-bound proteins, Protein A/ G PLUS-Agarose (Santa Cruz Biotech) was added and incubated at 48C for 4 h with mixing. Immunoprecipitates were then washed four times with NP40 lysis buffer, separated by SDS-PAGE and analyzed by immunoblotting as shown earlier.
RNA purification and RT-PCR
Total RNA was obtained from Xenopus animal caps or whole embryos by use of RNAzol (Tel-test) according to the manufacturer's instructions. RT-PCR analyses were performed as previously described. Primers corresponding to Xbra and EF-1a were used as previously described (Hoppler et al., 1996) .
Whole-mount in situ hybridization
Embryos were fixed in MEMPFA (pH 7.4). Whole-mount in situ hybridization was performed by the method of Sive et al. (2000) . All probes were generated by use of the MEGAscript Kit (Ambion) with DIG RNA Labeling Mix (Boehringer Mannheim).
